SITA-M 50/500MG TAB
Original price was: ₹104.00.₹93.60Current price is: ₹93.60.
Sita-M 50/500mg Tablet is a pharmaceutical product containing Metformin and Sitagliptin Phosphate for the treatment of type 2 diabetes.
Out of stock
Description
Sita-M 50/500mg Tablet is a pharmaceutical product that contains a combination of two active ingredients: Metformin and Sitagliptin Phosphate. Metformin belongs to the class of drugs known as biguanides, while Sitagliptin Phosphate is a dipeptidyl peptidase-4 (DPP-4) inhibitor.
This combination medication is primarily used for the treatment of type 2 diabetes mellitus. It helps to control blood sugar levels by improving insulin sensitivity and reducing the amount of glucose produced by the liver.
Sita-M 50/500mg Tablet is particularly indicated for diabetic patients who are unable to achieve glycemic control with either Metformin or Sitagliptin alone. By combining the two drugs, it provides an optimal effect in managing blood sugar levels.
Some of the ailments in which Sita-M 50/500mg Tablet is commonly used include:
1. Type 2 Diabetes Mellitus: This medication is effective in improving glycemic control, reducing fasting plasma glucose levels, and managing HbA1c levels in patients with type 2 diabetes.
The mechanism of action of Sita-M 50/500mg Tablet involves:
1. Metformin: It reduces hepatic glucose production, decreases intestinal absorption of glucose, and improves insulin sensitivity, thereby helping to lower blood sugar levels.
2. Sitagliptin Phosphate: It works by inhibiting the enzyme DPP-4, which normally degrades the hormone incretins. By inhibiting DPP-4, it increases the concentration of active incretins, which in turn stimulates insulin release while suppressing glucagon secretion.
In conclusion, Sita-M 50/500mg Tablet is a combination medication used for the management of type 2 diabetes mellitus. It effectively controls blood sugar levels by improving insulin sensitivity and reducing glucose production. Sita-M 50/500mg Tablet is recommended for patients who are unable to achieve adequate glycemic control with either Metformin or Sitagliptin alone. However, it is important to consult a healthcare professional before starting or changing any medication regime.
Additional information
| Weight | 35.0 g |
|---|---|
| Marketed by | |
| Composition | |
| Dosage form | TABLET |
| Prescription | REQUIRED |
| Therapeutic use | ANTI DIABETICS |
Note: The actual product packaging may vary slightly from the images shown on our website. Due to manufacturer updates, there may be variations in packaging design. We strive to provide accurate representations of all products.
